FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2043261641> ?p ?o ?g. }

• W2043261641 endingPage "E5" @default.
• W2043261641 startingPage "E5" @default.
• W2043261641 abstract "Glioblastoma multiforme (GBM) invasiveness is a complex process that involves recognition and attachment of GBM cells to particular extracellular matrix (ECM) molecules prior to migrating into proteolytically modified matrix and inducing angiogenesis. The CD44, which is a transmembrane adhesion molecule found on a wide variety of cells including GBM, has been suggested as the principal mediator of migration and invasion. The aim of the present study was to demonstrate whether an antibody specific to the standard form of CD44 (CD44s, 85-90 kDa) might prevent invasion and thus disrupt progression of C6 GBM in vivo. Immunostaining demonstrated homogenous expression of CD44s on the surface of C6 GBM cells and tumors. Flow cytometric analysis demonstrated binding saturation of anti-CD44s mAb to the receptor at 1 μg/5 X 10 5 cells. Blocking of CD44s in vitro resulted in a dose-dependent progressive (up to 94 ± 2.7%; mean ± standard deviation [SD]) detachment of C6 cells from ECM-coated culture surfaces. Blocking of CD44s in vivo resulted in significantly reduced C6 brain tumors (3.6 ± 0.4% [SD])--measured as the quotient: tumor surface (mm 2 )/brain surface (mm 2 ) X 100--as compared with untreated (19.9% ± 0.9%) or sham-treated rats (19.2 ± 1.1% to 19.3 ± 2.5% [SD]). Disruption of C6 GBM progression correlated with an improved food intake; treated rats were significantly less cachectic (166.6 ± 16.4 g [SD]) than those that were untreated (83.0 ± 2.7 g [SD]) or sham-treated (83.4 ± 1.1 g to 83.0 ± 2.2 g [SD]) rats. The authors conclude that CD44s-targeted treatment with specific mAb may represent an effective means for preventing progression of highly invasive GBMs." @default.
• W2043261641 created "2016-06-24" @default.
• W2043261641 creator A5020151381 @default.
• W2043261641 creator A5023178784 @default.
• W2043261641 creator A5034342886 @default.
• W2043261641 creator A5034832471 @default.
• W2043261641 creator A5047709051 @default.
• W2043261641 creator A5052658277 @default.
• W2043261641 creator A5053473059 @default.
• W2043261641 creator A5075807880 @default.
• W2043261641 creator A5091009980 @default.
• W2043261641 date "1999-08-01" @default.
• W2043261641 modified "2023-10-11" @default.
• W2043261641 title "In vivo treatment with anti-CD44 monoclonal antibody disrupts intracerebral progression of C6 glioblastoma" @default.
• W2043261641 cites W1487425110 @default.
• W2043261641 cites W1553199687 @default.
• W2043261641 cites W1971806728 @default.
• W2043261641 cites W1972325525 @default.
• W2043261641 cites W1974861766 @default.
• W2043261641 cites W1975595527 @default.
• W2043261641 cites W1989777836 @default.
• W2043261641 cites W1995104908 @default.
• W2043261641 cites W1995391609 @default.
• W2043261641 cites W1996787107 @default.
• W2043261641 cites W1999801319 @default.
• W2043261641 cites W2018006042 @default.
• W2043261641 cites W2043527956 @default.
• W2043261641 cites W2048407657 @default.
• W2043261641 cites W2061314975 @default.
• W2043261641 cites W2064326439 @default.
• W2043261641 cites W2067356899 @default.
• W2043261641 cites W2087532087 @default.
• W2043261641 cites W2089030187 @default.
• W2043261641 cites W2097863314 @default.
• W2043261641 cites W2116846203 @default.
• W2043261641 cites W2140481166 @default.
• W2043261641 cites W2141386649 @default.
• W2043261641 cites W2143762419 @default.
• W2043261641 cites W4241439079 @default.
• W2043261641 doi "https://doi.org/10.3171/foc.1999.7.2.5" @default.
• W2043261641 hasPublicationYear "1999" @default.
• W2043261641 type Work @default.
• W2043261641 sameAs 2043261641 @default.
• W2043261641 citedByCount "0" @default.
• W2043261641 crossrefType "journal-article" @default.
• W2043261641 hasAuthorship W2043261641A5020151381 @default.
• W2043261641 hasAuthorship W2043261641A5023178784 @default.
• W2043261641 hasAuthorship W2043261641A5034342886 @default.
• W2043261641 hasAuthorship W2043261641A5034832471 @default.
• W2043261641 hasAuthorship W2043261641A5047709051 @default.
• W2043261641 hasAuthorship W2043261641A5052658277 @default.
• W2043261641 hasAuthorship W2043261641A5053473059 @default.
• W2043261641 hasAuthorship W2043261641A5075807880 @default.
• W2043261641 hasAuthorship W2043261641A5091009980 @default.
• W2043261641 hasBestOaLocation W20432616411 @default.
• W2043261641 hasConcept C142724271 @default.
• W2043261641 hasConcept C150903083 @default.
• W2043261641 hasConcept C159654299 @default.
• W2043261641 hasConcept C16224149 @default.
• W2043261641 hasConcept C185592680 @default.
• W2043261641 hasConcept C189165786 @default.
• W2043261641 hasConcept C202751555 @default.
• W2043261641 hasConcept C203014093 @default.
• W2043261641 hasConcept C204232928 @default.
• W2043261641 hasConcept C207001950 @default.
• W2043261641 hasConcept C2778227246 @default.
• W2043261641 hasConcept C2780394083 @default.
• W2043261641 hasConcept C2780932548 @default.
• W2043261641 hasConcept C4224716 @default.
• W2043261641 hasConcept C502942594 @default.
• W2043261641 hasConcept C542903549 @default.
• W2043261641 hasConcept C55493867 @default.
• W2043261641 hasConcept C71924100 @default.
• W2043261641 hasConcept C86803240 @default.
• W2043261641 hasConcept C95444343 @default.
• W2043261641 hasConceptScore W2043261641C142724271 @default.
• W2043261641 hasConceptScore W2043261641C150903083 @default.
• W2043261641 hasConceptScore W2043261641C159654299 @default.
• W2043261641 hasConceptScore W2043261641C16224149 @default.
• W2043261641 hasConceptScore W2043261641C185592680 @default.
• W2043261641 hasConceptScore W2043261641C189165786 @default.
• W2043261641 hasConceptScore W2043261641C202751555 @default.
• W2043261641 hasConceptScore W2043261641C203014093 @default.
• W2043261641 hasConceptScore W2043261641C204232928 @default.
• W2043261641 hasConceptScore W2043261641C207001950 @default.
• W2043261641 hasConceptScore W2043261641C2778227246 @default.
• W2043261641 hasConceptScore W2043261641C2780394083 @default.
• W2043261641 hasConceptScore W2043261641C2780932548 @default.
• W2043261641 hasConceptScore W2043261641C4224716 @default.
• W2043261641 hasConceptScore W2043261641C502942594 @default.
• W2043261641 hasConceptScore W2043261641C542903549 @default.
• W2043261641 hasConceptScore W2043261641C55493867 @default.
• W2043261641 hasConceptScore W2043261641C71924100 @default.
• W2043261641 hasConceptScore W2043261641C86803240 @default.
• W2043261641 hasConceptScore W2043261641C95444343 @default.
• W2043261641 hasIssue "2" @default.
• W2043261641 hasLocation W20432616411 @default.
• W2043261641 hasOpenAccess W2043261641 @default.

• next